Save Product
Product Details
Source
Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (SP34-2) is a monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which provides higher batch consistency and long term security of supply.
Antibody Type
Recombinant Monoclonal
Clone
SP34-2
Isotype
Mouse IgG1, Kappa
Host Species
Mouse
Reactivity
Human
Immunogen
Purified Human CD3ε Protein
Specificity
This product is a specific antibody specifically reacts with CD3 epsilon protein.
Application
ELISA (Evaluation of levels of CD3 epsilon protein).
Flow Cytometry (Evaluation of an epitope within the extracellular domain of CD3 epsilon protein).
Form
Liquid
Formulation
Supplied as 0.2 μm-filtered solution in PBS (pH 7.4) containing 10% glycerol, with trehalose as protectant.
Please contact us for customized product forms or formulations.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 12 months under sterile conditions.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Bioactivity-FACS
2e5 of Jurkat cells were stained with 100 μL of 10 μg/mL of Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (SP34-2) (Cat. No. CDE-M531) and isotype control antibody respectively, washed and then followed by PE-anti mouse IgG1 antibody and analyzed with FACS (Routinely tested).
Protocol
Bioactivity-ELISA
Immobilized Human CD3 epsilon, His Tag (Cat. No. CDE-H5223) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (SP34-2) (Cat. No. CDE-M531) with a linear range of 0.4-6 ng/mL (QC tested).
Protocol
Customer Reviews Writing Reviews
Background
Recent Advances
Drug Development Progress- English Name：
T cell surface glycoprotein CD3
- Category：
- Approved Drugs：
10 Details
- Drugs in Clinical Trials：
198 Details
- Highest Development Stage：
Approved
Contact Us
Drug Candidate Licensing
